Our Team can assist in developing and maintaining RMPs and REMS across countries to help identify the factors that affect a drug’s risk profile.
The identification and assessment of safety signals related to the use of a pharmaceutical product are crucial components of ongoing pharmacovigilance monitoring and updating the crucial data on the known risk-benefit balance, which ultimately helps to protect consumers by better informing prescribers and dispensers of medication.
PVG Pharmasciences provides client support in carrying out signal identification tasks on a variety of data sources, including case data recorded in databases (safety and/or clinical), literature analysis, regulatory websites, and other data sources.
In order to find and assess new signals, we conduct a systematic cumulative examination of the information from all pertinent sources on an agreed-upon and known frequency.
Our Team can assist in developing and maintaining RMPs and REMS across countries to help identify the factors that affect a drug’s risk profile.
PVG Pharmasciences is looking for variety of roles, and talented individuals to join our team
Drop your CV at info@pvgpharmasciences.com
